The National Parkinson Foundation mentoring and networking program: Phase I the process
Objective: The National Parkinson Foundation (NPF) has focused on meeting the needs in the care and treatment of Parkinson's disease (PD). Through the Centers of…The relationship between body composition and postural instability in idiopathic Parkinson’s disease
Objective: There appears to be no research that has focused on the relationship between body composition phenotype and postural instability in IPD. The aim of…Predicting poor functional outcome in Parkinson’s disease
Objective: We aimed to describe progression to, identify independent prognostic factors for, and develop a valid prognostic model for, dependency and “death or dependency” in…Motor symptoms in patients with early stages of Parkinson’s disease
Objective: To determine the range of motor symptoms in PD patients on early stages and their the influence on quality of life and daily activities.…Quality of life and living with Parkinson’s in Ireland
Objective: (1) Assess the quality of life (QoL) for people with Parkinson's and explore associations between (QoL) and demographics (2) Investigate incidence of depression and…The method of biofeedback training for the patients with Parkinson’s disease
Objective: The objective of the research was to develop a biofeedback training method for the patients with Parkinson's disease (PD), utilizing videomotion analysis for the…Inflammatory profile discriminates clinical subtypes in LRRK2-associated PD
Objective: To evaluate whether inflammatory processes in PD patients with mutations in the LRRK2 gene (PD-LRRK2) are associated with modification of clinical features and disease…Do mutations in the TGM6 (SCA35) gene cause early-onset Parkinson’s disease?
Objective: To identify the genetic cause of early-onset Parkinson's disease (EOPD) in a Serbian family. Background: Hereditary EOPD is a genetically heterogeneous neurodegenerative disorder, characterized…Novel PLA2G6 c.1627C>T homozygous mutation and response to DBS-GPi
Objective: We present a novel homozygous PLA2G6 mutation and response to Deep Brain Stimulation (DBS). Background: Neurodegeneration with brain iron accumulation (NBIA) type 2/PLA2G6 is…Objective methods for quantifying the deep brain stimulation (DBS) efficacy in subthalamic-nuclei (STN) neurons with microelectrode recording (MER) technology
Objective: To design a computational modeling to develop a new diagnostic tool for effective neuro-medical-diagnostics for end users, to investigate and evaluate the potential benefits…
- « Previous Page
- 1
- …
- 361
- 362
- 363
- 364
- 365
- …
- 405
- Next Page »